Ghrelin Receptor Agonists for Anti-Aging: Reversing Multiple Age-Related Declines
GHS-R1a agonists show potential as anti-aging interventions by simultaneously restoring GH/IGF-1 axis, improving body composition, enhancing cardiovascular function, boosting immunity, and supporting cognition in aging.
Quick Facts
What This Study Found
Ghrelin receptor agonists demonstrate multi-system anti-aging potential: restoring GH/IGF-1 axis, improving body composition (lean mass/fat ratio), enhancing cardiac function, boosting immune competence, and supporting cognitive function in aging models — comprehensive geroscience intervention.
Key Numbers
How They Did This
review study.
Why This Research Matters
Relevant for ghrp, mk-677, anti-aging, hormone-optimization.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding Ghrelin receptor agonists demonstrate multi-system anti-aging potential: restoring GH/IGF-1 axis, improving body composition (lean mass/fat ratio), en
- Evidence Grade:
- moderate evidence.
- Study Age:
- Published in 2007.
- Original Title:
- Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging.
- Published In:
- Annals of the New York Academy of Sciences, 1119, 147-64 (2007)
- Authors:
- Smith, Roy G(7), Sun, Yuxiang(3), Jiang, Hong(2), Albarran-Zeckler, Rosie, Timchenko, Nikolai
- Database ID:
- RPEP-01290
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What was studied?
Ghrelin Receptor Agonists for Anti-Aging: Reversing Multiple Age-Related Declines
What was found?
GHS-R1a agonists show potential as anti-aging interventions by simultaneously restoring GH/IGF-1 axis, improving body composition, enhancing cardiovascular function, boosting immunity, and supporting cognition in aging.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01290APA
Smith, Roy G; Sun, Yuxiang; Jiang, Hong; Albarran-Zeckler, Rosie; Timchenko, Nikolai. (2007). Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging.. Annals of the New York Academy of Sciences, 1119, 147-64.
MLA
Smith, Roy G, et al. "Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging.." Annals of the New York Academy of Sciences, 2007.
RethinkPeptides
RethinkPeptides Research Database. "Ghrelin receptor (GHS-R1A) agonists show potential as interv..." RPEP-01290. Retrieved from https://rethinkpeptides.com/research/smith-2007-ghrelin-receptor-ghsr1a-agonists
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.